| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 47.630 | 44.007 | 45.567 | 51.595 | 66.060 | 64.157 | 66.725 | 93.700 | 105.132 | 124.016 |
| Total Income - EUR | 47.658 | 44.074 | 45.569 | 51.710 | 66.060 | 67.259 | 66.726 | 94.113 | 106.353 | 125.710 |
| Total Expenses - EUR | 36.507 | 36.239 | 40.447 | 40.607 | 43.588 | 46.103 | 55.184 | 51.902 | 52.762 | 71.676 |
| Gross Profit/Loss - EUR | 11.151 | 7.835 | 5.123 | 11.103 | 22.472 | 21.156 | 11.541 | 42.211 | 53.591 | 54.033 |
| Net Profit/Loss - EUR | 9.721 | 7.395 | 4.667 | 10.799 | 21.811 | 20.562 | 10.874 | 41.291 | 52.550 | 50.724 |
| Employees | 4 | 4 | 4 | 3 | 3 | 3 | 4 | 3 | 3 | 3 |
Check the financial reports for the company - Camidan-Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 7.861 | 4.805 | 1.572 | 2.725 | 1.434 | 14.032 | 18.009 | 12.743 | 7.420 | 2.950 |
| Current Assets | 42.918 | 31.358 | 37.953 | 50.407 | 31.300 | 38.098 | 49.979 | 17.790 | 45.098 | 90.264 |
| Inventories | 707 | 758 | 873 | 996 | 0 | 40 | 7.146 | 0 | 0 | 0 |
| Receivables | 7.576 | 3.686 | 3.853 | 4.419 | 5.808 | 2.761 | 26.881 | 6.258 | 33.546 | 51.209 |
| Cash | 34.635 | 26.914 | 33.227 | 44.992 | 25.491 | 35.297 | 15.952 | 11.533 | 11.552 | 39.055 |
| Shareholders Funds | 48.720 | 33.350 | 37.453 | 47.564 | 26.308 | 46.372 | 56.217 | 10.915 | 47.731 | 57.418 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 2.058 | 2.812 | 2.073 | 5.568 | 6.425 | 5.758 | 11.771 | 19.618 | 4.787 | 35.796 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Camidan-Med S.r.l.